US Patent Issued to GENOVIE on April 8 for "Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens" (Swedish Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,270,047, issued on April 8, was assigned to GENOVIE AB (Sodertalje, Sweden).

"Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens" was invented by Reagan Micheal Jarvis (Karlskrona, Sweden), Ryan Edward Hill (Karlskrona, Sweden) and Luke Benjamin Pase (Karlskrona, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to A multicomponent system wherein a first component is an engineered antigen-presenting cell (eAPC) designated component A and a second component is a genetic donor vector, designated component C, for delivery of one or more ORFs encoding an analyte...